NEW YORK, NY / ACCESSWIRE / November 20, 2018 / Wall Street posted sharp losses on Monday as
“Tech continues to be caught in the crosshairs of the triple threat of rising interest rates, global growth fears and trade tensions with China,” according to a chief investment officer at Independent Advisor Alliance, Chris Zaccarelli. “Trade war concerns with China weigh on the global supply chain for large technology companies while global growth fears worry many that future earnings will be lower,” Zaccarelli added.
The Market Edge Initiates Coverage on:
AstraZeneca's stock moved 0.32% higher Monday, to close the day at $40.80. The stock recorded a trading volume of 6,167,488 shares, which was above its three months average volume of 4,245,535 shares. In the last year, AstraZeneca's shares have traded in a range of 31.99 - 41.78. The share price has gained 27.54% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $37.66 is above its 200-day moving average of $39.13. Shares of the company are trading at a Price to Earnings ratio of 38.67. Shares of AstraZeneca have gained roughly 4.06 percent in the past month and are up 17.58 percent year-to-date.
Access The Market Edge’s AstraZeneca PLC Research Report at:
On Monday, shares of AbbVie recorded a trading volume of 5,971,688 shares, which was above the three months average volume of 6,027,276 shares. The stock ended the day 2.24% lower at $89.48. The share price has fallen 28.91% from its 52
Access The Market Edge’s AbbVie Inc. Research Report at:
The Market Edge
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered
For any questions, inquiries, or comments reach out to us directly at:
The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.